Erratum: MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors (International Journal of Cancer (2009) 124:8 (1778-1784) DOI: 10.1002/ijc.24150)

T. Kubo, H. Yamamoto, W. W. Lockwood, I. Valencia, J. Soh, M. Peyton, M. Jida, H. Otani, T. Fujii, M. Ouchida, N. Takigawa, K. Kiura, K. Shimizu, H. Date, J. D. Minna, M. Varella-Garcia, W. L. Lam, A. F. Gazdar, S. Toyooka

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Erratum: MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors (International Journal of Cancer (2009) 124:8 (1778-1784) DOI: 10.1002/ijc.24150)'. Together they form a unique fingerprint.